ASC denial management is becoming an EBITDA protection strategy because every preventable denial erodes net realized revenue at the exact margin line that determines valuation multiples, physician distributions, and lender covenant compliance. HFMA considers 5 to 10% the acceptable denial rate benchmark for healthcare organizations broadly, while well-run ASCs are expected to hold denial rates […]
Why ASC Denial Management Is Becoming an EBITDA Protection Strategy









